Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18834635rdf:typepubmed:Citationlld:pubmed
pubmed-article:18834635lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:18834635lifeskim:mentionsumls-concept:C0006309lld:lifeskim
pubmed-article:18834635lifeskim:mentionsumls-concept:C0262926lld:lifeskim
pubmed-article:18834635lifeskim:mentionsumls-concept:C0011900lld:lifeskim
pubmed-article:18834635lifeskim:mentionsumls-concept:C2004062lld:lifeskim
pubmed-article:18834635lifeskim:mentionsumls-concept:C0205178lld:lifeskim
pubmed-article:18834635lifeskim:mentionsumls-concept:C0015219lld:lifeskim
pubmed-article:18834635lifeskim:mentionsumls-concept:C0205473lld:lifeskim
pubmed-article:18834635pubmed:issue5lld:pubmed
pubmed-article:18834635pubmed:dateCreated2008-11-21lld:pubmed
pubmed-article:18834635pubmed:abstractTextSerological diagnosis of human brucellosis is problematic in endemic brucellosis regions and with patients having a history of brucellosis. The aim of this study is to ascertain the serologic and evolutionary behavior of the tests of serum agglutination, Coombs anti-Brucella, immunocapture-agglutination, enzyme-linked immunosorbent assay (ELISA) IgG, IgA, IgM and ELISA-IgG avidity against Brucella lipopolysaccharide (S-LPS), in patients with acute brucellosis based on whether or not a history of brucellosis exists. Titers and seropositivity in all the tests assayed were higher in the patients having brucellosis history (from 90.9% in ELISA-IgM to 100% in ELISA-IgG) than in the patients lacking such history (from 79.3% in ELISA-IgM to 86.2% in Coombs, immunocapture-agglutination, and ELISA-IgG). IgG S-LPS avidity results in patients with brucellosis history were significantly higher (always over 84%) than in patients without brucellosis history (from 48.0% in the initial sera to 81% ten months later) (p<0.001). The titers of antibodies against Brucella in the initial sera and ELISA-IgG avidity against S-LPS may allow distinguishing patients with brucellosis caused by primary infection in the initial stages of the disease from patients seropositive due to prior infections from Brucella.lld:pubmed
pubmed-article:18834635pubmed:languageenglld:pubmed
pubmed-article:18834635pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18834635pubmed:citationSubsetIMlld:pubmed
pubmed-article:18834635pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18834635pubmed:statusMEDLINElld:pubmed
pubmed-article:18834635pubmed:monthNovlld:pubmed
pubmed-article:18834635pubmed:issn1532-2742lld:pubmed
pubmed-article:18834635pubmed:authorpubmed-author:Rodríguez...lld:pubmed
pubmed-article:18834635pubmed:authorpubmed-author:ColmeneroJuan...lld:pubmed
pubmed-article:18834635pubmed:authorpubmed-author:VizcaínoNieve...lld:pubmed
pubmed-article:18834635pubmed:authorpubmed-author:OrduñaAntonio...lld:pubmed
pubmed-article:18834635pubmed:authorpubmed-author:BratosMiguel...lld:pubmed
pubmed-article:18834635pubmed:authorpubmed-author:AlmarazAnaAlld:pubmed
pubmed-article:18834635pubmed:authorpubmed-author:Fernández-Lag...lld:pubmed
pubmed-article:18834635pubmed:authorpubmed-author:MantecónMaría...lld:pubmed
pubmed-article:18834635pubmed:authorpubmed-author:GutiérrezMarí...lld:pubmed
pubmed-article:18834635pubmed:authorpubmed-author:ZarzosaMaría...lld:pubmed
pubmed-article:18834635pubmed:authorpubmed-author:CuberoAfricaAlld:pubmed
pubmed-article:18834635pubmed:authorpubmed-author:MuñozMaria...lld:pubmed
pubmed-article:18834635pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18834635pubmed:volume57lld:pubmed
pubmed-article:18834635pubmed:ownerNLMlld:pubmed
pubmed-article:18834635pubmed:authorsCompleteYlld:pubmed
pubmed-article:18834635pubmed:pagination397-403lld:pubmed
pubmed-article:18834635pubmed:meshHeadingpubmed-meshheading:18834635...lld:pubmed
pubmed-article:18834635pubmed:meshHeadingpubmed-meshheading:18834635...lld:pubmed
pubmed-article:18834635pubmed:meshHeadingpubmed-meshheading:18834635...lld:pubmed
pubmed-article:18834635pubmed:meshHeadingpubmed-meshheading:18834635...lld:pubmed
pubmed-article:18834635pubmed:meshHeadingpubmed-meshheading:18834635...lld:pubmed
pubmed-article:18834635pubmed:meshHeadingpubmed-meshheading:18834635...lld:pubmed
pubmed-article:18834635pubmed:meshHeadingpubmed-meshheading:18834635...lld:pubmed
pubmed-article:18834635pubmed:meshHeadingpubmed-meshheading:18834635...lld:pubmed
pubmed-article:18834635pubmed:meshHeadingpubmed-meshheading:18834635...lld:pubmed
pubmed-article:18834635pubmed:meshHeadingpubmed-meshheading:18834635...lld:pubmed
pubmed-article:18834635pubmed:meshHeadingpubmed-meshheading:18834635...lld:pubmed
pubmed-article:18834635pubmed:meshHeadingpubmed-meshheading:18834635...lld:pubmed
pubmed-article:18834635pubmed:meshHeadingpubmed-meshheading:18834635...lld:pubmed
pubmed-article:18834635pubmed:meshHeadingpubmed-meshheading:18834635...lld:pubmed
pubmed-article:18834635pubmed:meshHeadingpubmed-meshheading:18834635...lld:pubmed
pubmed-article:18834635pubmed:meshHeadingpubmed-meshheading:18834635...lld:pubmed
pubmed-article:18834635pubmed:meshHeadingpubmed-meshheading:18834635...lld:pubmed
pubmed-article:18834635pubmed:meshHeadingpubmed-meshheading:18834635...lld:pubmed
pubmed-article:18834635pubmed:year2008lld:pubmed
pubmed-article:18834635pubmed:articleTitleInfluence of brucellosis history on serological diagnosis and evolution of patients with acute brucellosis.lld:pubmed
pubmed-article:18834635pubmed:affiliationUnidad de Investigación, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.lld:pubmed
pubmed-article:18834635pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18834635pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18834635lld:pubmed